Central Government Caps Profit on Cancer Medicines at 30%

The central government has capped the profit on cancer medicines at a maximum of 30% of the original cost. This move follows concerns raised by Karnataka's Health Department and Health Minister U.T. Khadar regarding the pricing and profit margins of cancer drugs. Khadar had highlighted discrepancies, citing examples where medicines costing 86 rupees were sold for 4,528 rupees, and 160 rupees for 7,110 rupees.